Documents
Datasheet SDS Dabrafenib (GSK2118436) is a small molecule which can act as a B-Raf mutant inhibitor. It is provided as an off-white powder. This product acts on the following target types: Kinase.
This product acts on the following biochemical pathways: Autophagy.
This product may be of interest in the following research areas and diseases: Cellular stress, Cell death, Cancer.
This product may act as a Coronavirus inhibitor: Inibits NEK9, which interacts with SARS-CoV-2 Nsp9. Please note that our chemical products are for scientific research use only and are not for medical or veterinary use. This product can only be dispatched to a scientific business or laboratory address.
Research Articles on Dabrafenib
This product acts on the following biochemical pathways: Autophagy.
This product may be of interest in the following research areas and diseases: Cellular stress, Cell death, Cancer.
This product may act as a Coronavirus inhibitor: Inibits NEK9, which interacts with SARS-CoV-2 Nsp9. Please note that our chemical products are for scientific research use only and are not for medical or veterinary use. This product can only be dispatched to a scientific business or laboratory address.
| Target | Dabrafenib |
| Form | Solid |
| Purity | > 98% (TLC). Conforms to structure by NMR. |
| Reconstitution | Soluble in DMSO (30 mg/ml) or ethanol (1 mg/ml, warm). |
| Storage | Store desiccated at -20 °C for up to 1 year. Solutions can be stored at -20 °C for up to 3 months. |
| Molecular Weight | 519.6 g/mol |
| Molecular Formula | C23H20F3N5O2S2 |
| Buffer | Not applicable. |
| CAS Number | 1195765-45-7 |
| Availability | Shipped within 5-10 working days. |
| Note | This product is for research use only. Not for human consumption, cosmetic, therapeutic or diagnostic use. |